期刊文献+

P-selectin、VCAM-1和VEGF三种细胞因子标志物联合检测对冠心病的诊断价值探讨 被引量:2

Three cytokines markers of P-selectin,VCAM-1 and VEGF for diagnosis of coronary heart disease
下载PDF
导出
摘要 目的探讨P-selectin、VCAM-1和VEGF三种细胞因子标志物对冠心病的诊断价值。方法使用流式细胞仪检测75例冠心病患者和80例健康对照组的P-selectin、VCAM-1和VEGF血清含量,用ROC曲线确定临界值并分析其对冠心病的诊断性能参数,以确定其临床诊断价值。结果冠心病患者P-selectin、VCAM-1和VEGF血清浓度水平在稳定型心绞痛患者组、不稳定型心绞痛患者组和急性心肌梗塞患者组之间差异均有显著意义(P<0.05);三项指标对冠心病诊断的cut-off值分别为9 855.2 ng/L、864.05 ng/L和94.55 ng/L,敏感性SE(%)分别为85.31%、84.03%和89.35%、特异性SP(%)分别83.84%、83.85%和92.56%,ROC曲线下面积(AUC)分别为0.942、0.931和0.947。结论血清P-selectin、VCAM-1和VEGF在冠心病的发生发展过程中起一定的作用,对冠心病的诊断和分层有一定的临床价值。 Objective To explore the value of three cytokine markers of P-selectin,VCAM-1 and VEGF on diagnosis of coronary artery disease.Methods P-selectin,VCAM-1 and VEGF serum levels in 75 cases with coronary heart disease and 80 control group were detected by using flow cytometry and made up the critical value and performance parameters for the diagnosis of coronary heart disease to determine clinical diagnosis by using ROC curve analysis.Results Coronary heart disease P-selectin,VCAM-1 and VEGF serum levels in pa...
出处 《贵州医药》 CAS 2011年第1期8-10,共3页 Guizhou Medical Journal
基金 贵州省科学技术基金(黔科合J字[2007]2113号) 贵州省科技计划课题(黔科合S字[2007]1057号)资助项目
关键词 流式细胞术 P-选择素(P-selectin) 血管细胞粘附分子-1 血管内皮细胞生长因子 冠心病 FCM P-selectin Vascular cell adhesion molecule-1 Vascular endothelial growth factor Coronary heart disease
  • 相关文献

参考文献7

  • 1屈晓冰,孙振球,陈美娟,陈珑珑.冠心病患者P-选择素水平及其与冠状动脉病变程度间的关系[J].中华流行病学杂志,2005,26(8):617-621. 被引量:33
  • 2Naki K.Concentration of soluble vascular cell adhesionmolecule-a (VCAM-1)correlate with expression ofVCAM-1 mRNA in the human athero sclerotic atotta. Coronary Artery Disease . 1995
  • 3Birot O J,Peinnequin A,Simler N,et al.Vascular en-dothelial growth factor exlpression in heart of rats ex-posed to hypobaric hypoxia:differential response be-tween mRNA and protein. Journal of Cellular Physiology . 2004
  • 4OSULLIVAN B P,LINDEN M D,FRELINGER A L, et al.Platelet activation in cystic fibrosis [ J]. Blood . 2005
  • 5Mulvihill NT,Foley JB,Walsh MA,et al.Relationship between intracoronary and peripheral expression of soluble cell adhesion molecules. International Journal of Cardiology . 2001
  • 6Inoue M,Itoh H,Ueda M,et al.Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions:Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation . 1998
  • 7Risau W.Mechanisms of angiogenesis. Nature . 1997

二级参考文献14

  • 1Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies : Part I. Circulation, 2003,108 : 1664-1672.
  • 2Shebuski R J, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther, 2002,300 : 729-735.
  • 3Carter AM, Anagnostopoulou K, Mansfield MW, et al. Soluble P-selectin levels, P-selectin polyrnorphisms and cardiovascular disease. J Thromb Haemost,2003,1 : 1718-1723.
  • 4Braunwald E, Antman EM, Beasley JW, et ah ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2000, 36:970-1062.
  • 5Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983,51 : 606.
  • 6Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( committee to revise the 1993 guidelines for percutaneous translurninal coronary angioplasty ). J Am Coll Cardiol,2001,37 : 2215-2239.
  • 7Johnson RC, Chapman SM, Dong ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest, 1997, 99 :1037-1040.
  • 8Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advance atherosclerosis in apoE-deficient mice.Circulation, 2000,101:2290-2295.
  • 9Phillips JW, Barringhaus KG, Sanders JM, et al. Single injection of P-selectin or P-selectin glycoprotein ligand 1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient Mice. Circulation,2003,107 : 2244-2249.
  • 10Hajicooi M, Sanati A, Ahmadieh A, et al. Circulating ICAM-1,VCAM-1 ,E-selectin,P-selectin and TNFalphaR Ⅱ in patients with coronary artery disease. Immunol Invest, 2003,32 : 245-257.

共引文献32

同被引文献39

  • 1秦光明,金亚平,王俊宏,于路,张松照.流式细胞术检测冠心病患者七种循环标志物的应用研究[J].中华检验医学杂志,2006,29(7):615-617. 被引量:5
  • 2Favaloro L,Diez M, Mendiz O, et al. High-dose plasmid- mediated VEGF gene transfer is safe in patients with severe isehemie heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial[J]. Catheter Card- iovasc Interv,2013,82(6) :899-906.
  • 3Calderon-Santiago M, Priego-Capote F, Galache-Osuna JG,et al. Determination of essential amino acids in hu- man serum by a targeting method based on automated SPE-LC-MS/MS: discrimination between artheroscle- rotic patients[J]. J Pharm Biomed Anal, 2012,70 (8) : 476-484.
  • 4Nakano T,Ninomiya T,Sumiyoshi S,et al. Chronic kid- ney disease is associated with neovascularization and in- traplaque hemorrhage in coronary atherosclerosis in eld- ers: results from the hisayama study[J]. Kidney Int, 2013,84(2): 373-380.
  • 5Amoli MM,Amiri P,Alborzi A,et al. VEGF gene mR- NA expression in patients with coronary artery disease [J]. Mol Biol Rep,2012,39(9) :8589-8595.
  • 6Baidya SG,Zeng QT. Helper T cells and atherosclerosis:the cyto- kine web[J]. Postgrad Med J, 2005,81(962) : 746-752.
  • 7Shi B,Du X,Wang Q,et al. Increased PD-1 on CD4+ CD28- T cell and soluble PD-1 ligand-1 in patients with T2DM, association with atherosclerotic macrovascular diseases [J]. Metabolism, 2013, 62 (1):778-785.
  • 8Wang CH, Hsieb IC, Cherng WJ, et al. Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyper-plasia after coronary stenting[J]. Heart Vessels, 2012,27 (1) :10-19.
  • 9Flego D,Severino A,Trotta F,et al. Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients[J], Basic Res Cardiol,2014,109(6) :448.
  • 10Kakizaki M, Nobori K, Watanabe H, et al. Increased circulating CD3+/CD31+T cells in patients with acute coronary syndrome [J]. Heart Vessels,2013,28(5) :566-569.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部